Nasal Polyps Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Nasal Polyps Treatment Market is Segmented by Drug Class (Corticosteroids, Antibiotics, Leukotriene Inhibitors, and Others), Route of Administration, Distribution Channel, and Geography

Market Snapshot

Nasal Polyps Treatment Market Summary
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: >6.2 %
Nasal Polyps Treatment Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Nasal Polyps Treatment Market is anticipated to witness a CAGR of nearly 6.2% during the forecast period. The major factors driving the growth of the market are the rising prevalence of various cancers, immunological disorders, and the increasing geriatric population.

For instance, the Centers for Disease Control and Prevention reports that in 2018, about 28.9 million adults in the United States were diagnosed with sinusitis which directly resulted in higher demand for the treatment fueling the growth of the market.

Furthermore, an increase in the R&D investment in pharmaceuticals with a strong pipeline of products is expected to boost the growth of the global market throughout the forecasted period.

Scope of the Report

As per the scope of the report, nasal polyps are soft, painless, fleshy benign growths inside the paranasal sinuses and in the lining of the nose due to chronic inflammation of the mucosa. Generally, nasal polyps may occur due to asthma, allergic infections, sinus infections, cystic fibrosis, etc. The major symptoms associated with nasal polyps are nasal congestion, sinofacial pain, and loss of sense of smell.

By Drug Class
Leukotriene Inhibitors
By Route of Administration
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
North America
United states
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Corticosteroids Segment by Drug Class is Expected to Hold the Largest Market Share in the Nasal Polyps Treatment Market

The corticosteroid segment is expected to account for the largest market share due to the increase in the demand for corticosteroids treatment and its availability in various dosage forms like injections, intranasal sprays, and drops according to the need of the patient. Also, the availability of various corticosteroids as topical formulations and aerosols which have the ability to decrease the size of nasal polyps, and thus heal the nasal polyps in patients has contributed to the significant share of revenue in the market. Furthermore, patient compliance for creams is more compared to other dosage forms available in the market.

Nasal Polyps Treatment Market : Persons aged 60 years or over, in millions, 2017, Global

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall nasal polyps treatment market throughout the forecast period. This is mainly due to the increasing incidence of various cancers and allergic disorders such as asthma, sinusitis, and more, research activities in the United States coupled with increased approvals from regulatory bodies are likely to drive the growth of the nasal polyps treatment market. 

The Asia Pacific is set to grow at the fastest rate during the forecast period, driven by the prevalence of allergic disorders and the steady growth of the pharmaceutical industry in recent years. China plays a pivotal role due in the Asia region to its high population and high extent of government initiatives to the healthcare sector. Ongoing trials in the region will further stimulate market growth in the region.

Nasal Polyps Treatment Market - Growth Rate by Region

Competitive Landscape

The Nasal Polyps Treatment Market is moderately competitive and consists of several major players. Few of the major players are developing novel delivery systems to treat nasal polyps. which is expected to impel the global nasal polyps treatment market growth. For instance, in 2018, Intersect ENT Inc. launched SINUVA, a sinus implant containing mometasone furoate that is used to treat nasal polyps. Futhermore, few key players are entering into partnerships to develop and increase their market position globally. Some of the companies which are currently dominating the market are Sanofi S.A, OptiNose US, Merck & Co Inc, Intersect ENT Inc, and GlaxoSmithKline PLC

Major Players

  1. Sanofi S.A

  2. OptiNose US

  3. Merck & Co Inc

  4. Intersect ENT Inc

  5. GlaxoSmithKline PLC

Nasal Polyps Treatment Market Concentration

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Various Immunological Disorders along with the Increasing Geriatric Population

      2. 4.2.2 Huge Product Pipeline of Nasal Polyps Treatment with Growing Research Activities

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost and Complications Associated with Sinus Surgeries

      2. 4.3.2 Adverse Reactions Associated with Steroid Therapies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Drug Class

      1. 5.1.1 Corticosteroids

      2. 5.1.2 Antibiotics

      3. 5.1.3 Leukotriene Inhibitors

      4. 5.1.4 Others

    2. 5.2 By Route of Administration

      1. 5.2.1 Oral

      2. 5.2.2 Nasal

      3. 5.2.3 Others

    3. 5.3 By Distribution Channel

      1. 5.3.1 Hospital Pharmacies

      2. 5.3.2 Retail Pharmacies

      3. 5.3.3 Online Pharmacies

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United states

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Sanofi S.A

      2. 6.1.2 OptiNose US

      3. 6.1.3 Merck & Co Inc.

      4. 6.1.4 Intersect ENT Inc.

      5. 6.1.5 GlaxoSmithKline PLC

      6. 6.1.6 Teva Pharmaceutical Industries Ltd.

      7. 6.1.7 Regeneron Pharmaceuticals Inc.

      8. 6.1.8 F. Hoffmann-La Roche AG

      9. 6.1.9 Novartis International AG

      10. 6.1.10 Norton Waterford Ltd

      11. 6.1.11 Pfizer Inc.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Nasal Polyps Treatment Market market is studied from 2018 - 2026.

The Nasal Polyps Treatment Market is growing at a CAGR of >6.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Sanofi S.A, OptiNose US, Merck & Co Inc, Intersect ENT Inc, GlaxoSmithKline PLC are the major companies operating in Nasal Polyps Treatment Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!